• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Samsung Biologics - Articles and news items

Samsung Bioepis seeks EU approval for its biosimilar adalimumab candidate, SB5

Industry news / 18 July 2016 / Victoria White, Digital Content Producer

At an estimated $4billion a year, the reference product, Humira, is among the European Union’s largest single drug expenditures…

Infliximab biosimilar Flixabi approved in the EU

Industry news / 31 May 2016 / Victoria White, Digital Content Producer

The EC has granted marketing authorisation in the European Union (EU) for Flixabi, an infliximab biosimilar referencing Remicade…

EC approves Benepali – the first biosimilar of Enbrel

Industry news / 18 January 2016 / Victoria White

Benepali is the first etanercept biosimilar referencing Enbrel to be approved in the EU, making it the first subcutaneous anti-TNF biosimilar available there…

Benepali receives positive opinion from CHMP

Industry news / 20 November 2015 / Victoria White

Previously known as SB4, Benepali (etanercept) is a biosimilar candidate to the reference product Enbrel…

Bristol Myers Squibb logo

Bristol-Myers Squibb and Samsung BioLogics expand manufacturing agreement

Industry news / 23 April 2014 / Bristol-Myers Squibb

Bristol-Myers Squibb Company and Samsung BioLogics announced the companies will increase the scope of their existing manufacturing agreement in which Samsung will manufacture commercial drug substances and drug product for several Bristol-Myers Squibb biologic medicines at its Incheon manufacturing site…

Bristol Myers Squibb logo

Bristol-Myers Squibb and Samsung BioLogics announce biopharmaceutical manufacturing relationship

Industry news, News / 29 July 2013 / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company and Samsung BioLogics announced the companies have entered into a 10-year agreement…

Biogen Idec logo

Samsung Biologics and Biogen Idec announce formation of biosimilars joint venture Samsung Bioepis

Industry news, News / 27 February 2012 / Biogen Idec

Samsung Biologics & Biogen Idec have established their joint venture…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +